Patents for A61P 35 - Antineoplastic agents (221,099) |
---|
12/12/1990 | EP0401394A1 Stable aqueous cisplatin solutions |
12/12/1990 | EP0401256A1 Optically pure dexniguldipine and its derivatives for treating tumorous diseases. |
12/12/1990 | EP0401243A1 Medicinal preparations characterized by a combination of cytostatic agents, hormonal therapeutic agents and phosphone derivatives. |
12/12/1990 | CN1047696A Anticancer antibiotic mz43-37f11 substance, the production and uses thereof |
12/12/1990 | CN1047695A Production method of a kind of nutrition liquid |
12/11/1990 | US4977177 Detection and treatment of tumors |
12/11/1990 | US4977147 Contraceptives, antitumor agents |
12/11/1990 | US4977138 FR901228 substance and preparation thereof |
12/11/1990 | CA1277656C Substituted androsta-1,4-diene-3,17-diones and process for their preparation |
12/11/1990 | CA1277614C Sialylated lewisx epitope, antibodies and diagnosis |
12/08/1990 | WO1990015059A1 Photosensitizing diels-alder porphyrin derivatives |
12/08/1990 | CA2056431A1 Photosensitizing diels-alder porphyrin derivatives |
12/08/1990 | CA2018253A1 Method of preparing n-oxo-tetrahydro-.beta.-carbolines |
12/07/1990 | WO1990014841A1 Pharmaceutical compositions and methods of treatment using alzheimer's amyloid polypeptides |
12/07/1990 | CA2018480A1 Anthracyclins, process for their preparation and medicaments containing the same |
12/07/1990 | CA2018067A1 Acylated derivatives of etoposide |
12/06/1990 | DE3917852A1 Medikamente zur tumortherapie mit kontrolliertem und reguliertem immunsystem sowie verwendung der einzelsubstanzen zur kombinierten therapie Drugs for tumor therapy with controlled and regulated immune system as well as use of individual substances for combined therapy |
12/06/1990 | CA2018280A1 Pyridobenzoindole derivatives, process for their preparation and compounds containing the same |
12/05/1990 | EP0401138A2 New anticancer antibiotic substance, the production and uses thereof |
12/05/1990 | EP0400971A2 Method for preparation of taxol |
12/05/1990 | EP0400586A1 Use of xylan polyhydrogensulphate in therapy of cell-proliferation dependent diseases |
12/05/1990 | EP0400562A1 Pyrrolopyrimidines, their production and use as tumoricidal agents |
12/05/1990 | EP0400480A1 A method for enhancing the cytotoxicity of anthracyclines through photoactivation |
12/05/1990 | EP0400464A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
12/05/1990 | EP0375773A4 Topical hematoporphyrin |
12/04/1990 | US4975531 Sakyomicin E and the derivatives thereof, a process for the preparation thereof and the use thereof |
12/04/1990 | US4975455 Antitumor, anticarcinogenic agent; skin disorders |
12/04/1990 | US4975454 Antitumor, anticancer agents |
12/04/1990 | US4975432 Improved blood flow |
12/04/1990 | US4975422 Angiogenesis inhibitor |
12/04/1990 | US4975369 Recombinant and chimeric KS1/4 antibodies directed against a human adenocarcinoma antigen |
12/02/1990 | CA2018133A1 Use of xylan polyhydrogensulfates for the therapy of disorders based on cell proliferation |
12/01/1990 | CA2017528A1 Monoclonal antibody reactive to a unique antigen widely present on various human leukemia and lymphoma cells and methods of using same for diagnosis and treatment |
11/30/1990 | CA2017648A1 Active compounds |
11/29/1990 | WO1990014432A1 A human cytokine, interleukin-9 |
11/29/1990 | WO1990014363A1 Metalloproteinase inhibitor |
11/29/1990 | WO1990014352A1 2-halo-9-(2-deoxy-2-fluoro-b-d-arabinofuranosyl) adenine nucleoside derivatives |
11/29/1990 | WO1990014340A1 Glutamic acid derivatives |
11/29/1990 | WO1990014104A1 Anti-idiotypic antibody which induces an immune response against a glycosphingolipid and use thereof |
11/29/1990 | CA2017680A1 Method for enhancing the cytotoxicity of anthracyclines through photoactivation |
11/29/1990 | CA2017604A1 Pyrrolopyrimidines, their production and use |
11/28/1990 | EP0399743A1 Phosphonomethylthio-alkoseypureine derivatives, intermediate products for their preparation and pharmaceutical compositions containing them |
11/28/1990 | EP0399685A1 Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13 |
11/28/1990 | EP0399631A1 Use of gestodene for the production of pharmaceutical agents |
11/28/1990 | EP0399519A2 Potentiating cell-mediated immunity utilizing polyamine derivatives |
11/28/1990 | EP0399505A1 Physiologically active compounds SN-198C and method and bacteria for their production |
11/28/1990 | EP0399444A1 New carcinostatic or antitumor antibiotic, conagenin, and production and uses thereof |
11/28/1990 | EP0399257A1 Cell surface antigen that binds with L6 Monoclonal antibody |
11/28/1990 | EP0398955A1 Diagnosis of retinoblastoma |
11/28/1990 | EP0398925A1 Growth inhibiting agent and the use thereof. |
11/28/1990 | CN1047298A Application for gestodene in manufacture of pharmaceutical |
11/28/1990 | CN1047204A Stable solution of rebeccamycin analog and preparation thereof |
11/28/1990 | CN1010587B Method for new salts preparation |
11/27/1990 | US4973755 Antiestrogens |
11/27/1990 | US4973693 Antitumor agents, microbiocides, chemical intermediates |
11/27/1990 | US4973592 1,3-diazocycloalkenes as muscarinic receptor blocking agents |
11/27/1990 | CA1276878C Radiolabeled antibody fragments |
11/26/1990 | CA2017446A1 Physiologically active material sn-198c production bacteria, novel physiologically active material sn-198c's and method for preparing same |
11/25/1990 | CA2017390A1 Compounds |
11/22/1990 | EP0398817A1 Interleukin 1 inhibitor |
11/22/1990 | EP0398753A2 Metalloproteinase inhibitor |
11/22/1990 | EP0398558A1 Isolation and structual elucidation of the cytostatic linear depsipeptide dolastatin 15 |
11/22/1990 | EP0398367A2 Dimeric epipodophyllotoxin glucoside derivatives |
11/22/1990 | EP0398336A1 Xanthocillin X monomethyl ether derivative and antitumor agent containing the same |
11/22/1990 | EP0398305A2 Anthracycline conjugates having a novel linker and methods for their production |
11/22/1990 | EP0398231A2 Nucleoside analogs |
11/22/1990 | EP0398024A1 Conjugates for tumor localization and/or tumortherapy |
11/22/1990 | EP0397821A1 A novel family of high affinity, modified antibodies for cancer treatment |
11/22/1990 | EP0376959A4 Platinum pharmaceuticals |
11/22/1990 | CA2017279A1 Process to prepare metastasis-inhibitory factor |
11/21/1990 | CN1047035A Novel antibody system for biological response modifiers |
11/20/1990 | WO1990014009A1 Therapeutic application of an anti-invasion compound |
11/20/1990 | US4971991 Physiological function enhancing agents activated by ultrasonic waves for the treatment of tumors |
11/20/1990 | US4971986 Arylhydrazones useful as SAMDC inhibitors |
11/20/1990 | US4971965 Antibiotics, antitumor agents, bactericides |
11/20/1990 | CA1276637C Pyrido 2,3-d pyrimidine derivatives |
11/20/1990 | CA1276633C Imidazo-pyridine derivatives |
11/20/1990 | CA1276632C Nitro derivatives of vinblastine-type bisindoles, pharmaceutical compositions containing them and process for preparing same |
11/19/1990 | CA2013425A1 Dimeric epipodophyllotoxin glucoside derivatives |
11/18/1990 | WO1990014360A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
11/18/1990 | CA2056981A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
11/18/1990 | CA2013766A1 Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13 |
11/17/1990 | CA2016895A1 Use of gestodene for the production of pharmaceutical agents |
11/15/1990 | WO1990013661A1 Autoantibodies which enhance the rate of a chemical reaction |
11/15/1990 | WO1990013643A2 Glycoprotein hormone receptor molecules |
11/15/1990 | WO1990013300A1 ENDOTHELIAL CELL-LEUKOCYTE ADHESION MOLECULES (ELAMs) AND MOLECULES INVOLVED IN LEUKOCYTE ADHESION (MILAs) |
11/15/1990 | WO1990013289A1 Antineoplastic solution and method for treating neoplasms |
11/14/1990 | EP0397635A1 Peptide with anti-metastasis activity |
11/14/1990 | EP0397567A1 Antitumor substance, process for its preparation and pharmaceutical compositions containing it |
11/14/1990 | EP0397556A1 N-Phenyl amides, methods for their preparation and medicaments containing them |
11/14/1990 | EP0397419A2 Novel tumor-associated antigen, antibodies, compositions and uses therefor |
11/14/1990 | EP0397336A2 Cell growth inhibitory macrocyclic lactone denominated combretastatin D-2 |
11/14/1990 | EP0397307A2 Water soluble high molecular polymerized drug preparation |
11/14/1990 | EP0397290A1 Novel derivatives, their preparation and pharmaceutical composition containing them |
11/14/1990 | EP0397213A1 Radiolabeled antibody fragments |
11/14/1990 | EP0397147A2 Stable solutions of rebeccamycin analog and preparation thereof |
11/14/1990 | EP0397060A2 Maleinimide derivatives and their use as medicines |
11/14/1990 | EP0396903A2 Use of IFN-gamma for the preparation of a pharmaceutical composition for the treatment of ATL |
11/14/1990 | EP0396841A1 Fluorinated arachidonic acid derivatives |
11/14/1990 | EP0396664A1 New derivatives of human/bovine basic fibroblast growth factor |